See the DrugPatentWatch profile for Ubrelvy
Ubrelvy is an oral medication approved for the acute treatment of migraine with or without aura in adults [1]. It belongs to a class of drugs called calcitonin gene-related peptide (CGRP) receptor antagonists [2]. Unlike older migraine medications that constrict blood vessels, Ubrelvy works by blocking the activity of CGRP, a molecule that is thought to play a role in migraine [3].
How does Ubrelvy work?
Ubrelvy's mechanism of action involves blocking the CGRP receptor. CGRP is a neuropeptide that is released during a migraine attack and is believed to contribute to the pain and inflammation associated with migraines [3]. By binding to the CGRP receptor, Ubrelvy prevents CGRP from exerting its effects, thereby alleviating migraine symptoms [2].
What is the difference between Ubrelvy and other migraine treatments?
Ubrelvy is a gepant, a newer class of acute migraine medications that target CGRP. This differs from older acute treatments such as triptans, which work by constricting blood vessels. For individuals who cannot take triptans due to cardiovascular contraindications or who have found triptans ineffective, gepants like Ubrelvy offer an alternative [3].
When should I take Ubrelvy?
Ubrelvy is intended for use at the first sign of a migraine attack [1]. It is not designed for migraine prevention [2].
What are the potential side effects of Ubrelvy?
Common side effects of Ubrelvy include nausea, fatigue, and dry mouth [1]. It is important to discuss any concerns about side effects with a healthcare provider [4].
Are there any Ubrelvy alternatives for migraine?
Other acute migraine treatments include triptans, NSAIDs, and combination analgesics. For migraine prevention, there are several classes of medications, including oral preventative medications, CGRP monoclonal antibodies administered by injection, and even devices [3][4].
What is the pricing and insurance coverage for Ubrelvy?
The cost of Ubrelvy can vary depending on insurance coverage and pharmacy pricing. Patients may be eligible for savings programs offered by the manufacturer [5]. Information on pricing and insurance can often be found on the drug's official website or through patient assistance programs [5].
What is the patent status for Ubrelvy?
Information regarding the patent status and exclusivity for Ubrelvy can be found on specialized pharmaceutical patent databases [6].
Who makes Ubrelvy?
Ubrelvy is manufactured by AbbVie Inc. [7].
What clinical data supports Ubrelvy's effectiveness?
Clinical trials have demonstrated Ubrelvy's efficacy in treating migraine. Studies have shown that a significant percentage of patients experienced pain freedom two hours after taking the medication, and many also reported the absence of their most bothersome migraine symptom [1].
Sources:
[1] https://www.ubrelvy.com/
[2] https://www.rxlist.com/ubrelvy-drug-market-status.htm
[3] https://migrainefoundation.org/living-with-migraine/treatment-options/medications/gepants/
[4] https://www.mayoclinic.org/diseases-conditions/migraine-headache/diagnosis-treatment/drc-20360204
[5] https://www.ubrelvy.com/savings-and-support
[6] https://drugpatentwatch.com/
[7] https://www.abbvie.com/